Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bolder BioTechnology Announces FDA Orphan Drug Designation for BBT-059

americanpharmaceuticalreviewJune 13, 2019

Tag: Bolder BioTechnology , FDA , Drug

PharmaSources Customer Service